DX-619, a Novel Des-Fluoro(6) Quinolone Manifesting Low Frequency of Selection of Resistant <i>Staphylococcus aureus</i> Mutants: Quinolone Resistance beyond Modification of Type II Topoisomerases
Jacob Strahilevitz(Hebrew University of Jerusalem), David C. Hooper(Massachusetts General Hospital), Q. C. Truong-Bolduc(Harvard University)
Cited by 20
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576
Plasmid-Mediated Quinolone Resistance
|Microbiology Spectrum|2014|469